Bone Marrow Mononuclear Cells Administration Restore Lysophosphatidic Acid (LPA) Levels and Cellular Signaling Axis in Rats Submitted to Renal Ischemia–Reperfusion
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26189186 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Paula Mattos-Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Biomembranas, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Ilha do Fundão, Rio de Janeiro 21941…. Hauptthemen laut MEDLINE: Lysophospholipids, Reperfusion Injury, Signal Transduction, Kidney. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAPES-PROBITEC, CNPq, FAPERJ.
Abstract (Originalsprache)
Bone marrow-derived mononuclear cells (BMMCs) have shown beneficial effects on tissue repair, largely attributed to the paracrine action of bioactive mediators such as lysophosphatidic acid (LPA). This study aimed to evaluate the effects of BMMC treatment in a rat model of renal ischemia/reperfusion (I/R) injury, focusing on LPA-related molecular pathways. Male Wistar rats were divided into three groups: control; I/R, subjected to bilateral renal artery clamping for 30 min followed by 24 h of reperfusion; and I/R + BMMC, which received 1 × 106 BMMCs per kidney directly into the renal capsule post-ischemia. During reperfusion, the rats were placed in metabolic cages for urine collection, renal function and protein expression. BMMC treatment did not reverse the I/R-induced increase in urine volume or decrease in glomerular filtration rate, serum potassium, or filtered sodium load. However, it prevented proteinuria, increased blood urea nitrogen, and enhanced urinary potassium excretion. Mechanistically, BMMC treatment prevented I/R-induced upregulation of LPAR1, downregulated LPAR2 and LPAR3, restored plasma LPA levels, and reduced renal autotaxin content. These results suggest that BMMCs modulate harmful LPA-related signaling and may contribute to renal protection through paracrine mechanisms in the setting of acute I/R injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Biomembranas, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Ilha do Fundão, Rio de Janeiro 21941-902, RJ, Brazil.
- Instituto de Ciências Médicas, Universidade Federal do Rio de Janeiro, Macaé 27930-560, RJ, Brazil.
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.
- Centro de Pesquisa em Medicina de Precisão, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.
ORCID-Profile: Lucienne S Lara, Marcelo Einicker-Lamas
Förderung
- CAPES-PROBITEC
- CNPq
- FAPERJ
Zitieren
APA
Mattos-Silva, P., Gonsalez, S. R., Lara, L. S., & Einicker-Lamas, M. (2025). Bone Marrow Mononuclear Cells Administration Restore Lysophosphatidic Acid (LPA) Levels and Cellular Signaling Axis in Rats Submitted to Renal Ischemia–Reperfusion. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189186
Vancouver
Mattos-Silva P, Gonsalez SR, Lara LS, Einicker-Lamas M. Bone Marrow Mononuclear Cells Administration Restore Lysophosphatidic Acid (LPA) Levels and Cellular Signaling Axis in Rats Submitted to Renal Ischemia–Reperfusion. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189186
BibTeX
@article{MattosSilva2025,
author = {Mattos-Silva, Paula and Gonsalez, Sabrina Ribeiro and Lara, Lucienne S and Einicker-Lamas, Marcelo},
title = {Bone Marrow Mononuclear Cells Administration Restore Lysophosphatidic Acid (LPA) Levels and Cellular Signaling Axis in Rats Submitted to Renal Ischemia–Reperfusion},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26189186}
}
EUVIMED